| Product Name |
CAS Registry Number |
Molecular Formula |
| H-D-HIS(3-ME)-OH | 163750-76-3 | C7H11N3O2 |
| H-D-HIS(1-ME)-OH | 163750-77-4 | C7H11N3O2 |
| hydroxyzine hydrochloride | 163837-37-4 | |
| hydroxyzine hydrochloride | 163837-38-5 | |
| H-D-TYR-ILE-ASN-LEU-ILE-D-THR-ARG-GLN-ARG-D-TYR-NH2 | 163887-48-7 | C61H99N19O15 |
| H-SER-LEU-ILE-GLY-ARG-LEU-OH | 164081-25-8 | C29H55N9O8 |
| Hexadecamethonium | 16414-68-9 | |
| HEXADECYLTRIMETHOXYSILANE | 16415-12-6 | C19H42O3Si |
| H-GLY-ALA-GLY-OH | 16422-05-2 | C7H13N3O4 |
| H-ALA-ALA-GLY-OH | 16422-07-4 | C8H15N3O4 |
| Hoxa-10 protein | 164384-16-1 | |
| H-GLY-GLY-NH2 HCL | 16438-42-9 | C4H10ClN3O2 |
| hexaammineruthenium triiodide | 16446-62-1 | H18I3N6Ru |
| Hexammineruthenium(III)Bromide | 16455-56-4 | Br3H18N6Ru |
| HEXAFLUOROACETONE IMINE | 1645-75-6 | C3HF6N |
| Hydromadinone | 16469-74-2 | |
| hydrogen 2-(3-(5,6-dichloro-1-ethyl-1,3-dihydro-3-(3-sulphonatobutyl)-2H-benzimidazol-2-ylidene)-1-propenyl)-1-(3-sulphonatopropyl)naphtho[1,2-d]thiazolium, sodium salt | 16470-44-3 | C30H30Cl2N3NaO6S3 |
| hydrogen -1-(3-sulphonatopropyl)-2-[2-[[1-(3-sulphonatopropyl)naphtho[1,2-d]thiazol-2(1H)-ylidene]methyl]-1-butenyl]naphtho[1,2-d]thiazolium, sodium salt | 16470-45-4 | C33H31N2NaO6S4 |
| Hemicholinium | 16478-59-4 | |
| H-ARG-GLY-PRO-CYS-ARG-ALA-PHE-ILE-OH | 164859-77-2 | C40H66N14O9S1 |
| H-MET-LYS-ARG-SER-ARG-GLY-PRO-SER-PRO-ARG-ARG-OH | 165174-60-7 | C53H98N24O14S |
| HERPES SIMPLEX VIRUS-I PROTEINASE SUBSTRATE II | 165174-61-8 | C102H151N25O30 |
| (H-GAMMA-GLU-CYS-BETANA)2 | 165174-63-0 | C36H40N6O8S2 |
| Homprenorphine | 16549-56-7 | C28H37NO4 |
| HYDROXYECTOINE | 165542-15-4 | C6H10N2O3 |
| HYDROXY NAPHTHOL BLUE | 165660-27-5 | C20H12N2Na2O11S3 |
| H-ARG-ARG-ARG-ARG-ARG-ARG-ARG-OH | 165893-48-1 | C42H86N28O8 |
| [hydroxy-[hydroxy-[[(2R,3S,5R)-3-hydroxy-5-(6-oxo-3H-purin-9-yl)oxolan-2-yl]methoxy]phosphoryl]oxy-phosphoryl]oxyphosphonic acid | 16595-02-1 | C10H15N4O13P3 |
| H-ASP-ALA-GLU-PHE-ARG-HIS-ASP-SER-GLY-TYR-GLU-VAL-HIS-HIS-GLN-LYS-LEU-VAL-PHE-PHE-ALA-GLU-ASP-VAL-GLY-SER-ASN-LYS-GLY-ALA-ILE-ILE-GLY-LEU-MET-VAL-GLY-GLY-VAL-VAL-ILE-ALA-OH | 166090-74-0 | C203H311N55O60S |
| H-PRA-OME HCL | 166271-28-9 | C6H10ClNO2 |
| hexanoylcholine | 16639-00-2 | |
| H-TYR(BZL)-OH | 16652-64-5 | C16H17NO3 |
| H-L-CYS(TRT)-NH2 HCL | 166737-85-5 | C22H23ClN2OS |
| H-ALA-PNA | 1668-13-9 | C9H11N3O3 |
| Hydrazinecarboxylic acid, 2-(2-pyridinyl)-, 1,1-dimethylethyl ester (9CI) | 166974-98-7 | C10H15N3O2 |
| Hexane, 1,1-dichloro-3-methyl- | 16703-32-5 | |
| H-ALA-ARG-OH | 16709-12-9 | C9H19N5O3 |
| HEPTANOPHENONE | 1671-75-6 | C13H18O |
| H-CYS(BZL)-OME HCL | 16741-80-3 | C11H16ClNO2S |
| HEPTANOICACID,LITHIUMSALT | 16761-13-0 | |
| H-ARG-VAL-LEU-(R)-PHE-GLU-ALA-NLE-NH2 | 167875-35-6 | C40H69N11O8 |
| H-HIS(BZL)-OH | 16832-24-9 | C13H15N3O2 |
| H-GAMMA-GLU-ABU-OH | 16869-42-4 | C9H16N2O5 |
| H-TRP-OTBU HCL | 16874-09-2 | C15H21ClN2O2 |
| H-GLN-ALA-OH | 16874-70-7 | C8H15N3O4 |
| H-HIS-ALA-OH | 16874-75-2 | C9H14N4O3 |
| H-HIS-PHE-OH | 16874-81-0 | C15H18N4O3 |
| H-THR-PHE-OH | 16875-27-7 | C13H18N2O4 |
| (HIS32,LEU34)-NEUROPEPTIDE Y (32-36) | 168916-68-5 | C33H54N14O6 |
| Hydrazinecarboxylic acid, (1-carboxyethylidene)-, 1-methyl ester (9CI) | 168921-76-4 | C5H8N2O4 |
| hafnium oxide sulphate | 16894-92-1 | HfO5S |
| HUMAN HCC-1 | 169146-44-5 | |
| HEXYL TIGLATE | 16930-96-4 | C11H20O2 |
| hexyl hex-2-enoate | 16930-97-5 | C12H22O2 |
| HEPTYL-CROTONATE | 16930-99-7 | C11H20O2 |
| H-D-ORN(Z)-OH | 16937-91-0 | C13H18N2O4 |
| Hexafluorophosphoric acid | 16940-81-1 | HPF6 |
| Hexachloroiridic acid hexahydrate | 16941-92-7 | H2IrCl6.6(H2O) |
| H-D-Glu(Otbu)-OMe.HCL | 16948-36-0 | |
| HEXAFLUOROANTIMONIC ACID | 16950-06-4 | F6HSb |
| H-ARG(PMC)-OTBU(FREE BASE) | 169543-81-1 | C24H40N4O5S |
| Hydroxypropyltrimonium Hydrolyzed Silk | 169590-61-8 | |
| HEXYLDECYL ESTER OF HYDROLYZED COLLAGEN | 169590-83-4 | |
| HYDROGEN TETRACHLOROAURATE(III) | 16961-25-4 | AuCl4H7O3 |
| Hexafluorosilicic acid | 16961-83-4 | H2SiF6 |
| hydroxyethylthiomethacrylate | 169682-76-2 | |
| hydroxyperezone | 16981-83-2 | |
| HEXADECENOIC ACID | 17004-51-2 | |
| H-THR(AC)-OH | 17012-42-9 | C6H11NO4 |
| HUMAN MIDKINE | 170138-17-7 | |
| Hydrazine, (4-methoxy-2-methylphenyl)- (9CI) | 170143-40-5 | C8H12N2O |
| Heptyl methyl methylphosphonate | 170275-60-2 | |
| H-SER-GLU-ILE-TRP-ARG-ASP-ILE-ASP-PHE-OH | 170294-35-6 | C54H77N13O17 |
| H-LYS-ALA-OH HYDROBROMIDE SALT | 17043-71-9 | C9H20BrN3O3 |
| HYDROXYMETHYL CELECOXIB | 170571-00-3 | C17H14F3N3O3S |
| HEXAFLUOROARSENIC ACID | 17068-85-8 | AsF6H |
| Hexanedioic acid, polymer with 1,4-cyclohexanedimethanol and oxiranylmethyl 2-methyl-2-propenoate | 170778-72-0 | |
| H-TYR(TBU)-OTBU HCL | 17083-23-7 | C17H28ClNO3 |
| H-SER(TBU)-OME HCL | 17083-26-0 | C8H18ClNO3 |
| HYDROGEN TETRABROMOAURATE (III) HYDRATE (99.9%-AU) | 17083-68-0 | C12H20Br4O2 |
| hydrogen [[N,N'-ethylenebis[N-(carboxymethyl)glycinato]](4-)-N,N',O,O',ON,ON']ferrate(1-) | 17099-81-9 | C10H12FeN2O8.H |
| H-SER(TBU)-OME HCL | 17114-97-5 | C8H18ClNO3 |
| H-Gly-Phe-Ala-OH | 1712-30-7 | |
| H-GLY-PHE-ALA-OH | 17123-30-7 | C14H19N3O4 |
| hepatic leukemia factor | 171237-36-8 | |
| HOMOAROMOLINE | 17132-74-0 | |
| H-BETA-ALA-LEU-OH | 17136-25-3 | C9H18N2O3 |
| H-BETA-ALA-PHE-OH | 17136-28-6 | C12H16N2O3 |
| H-SER-LEU-ILE-GLY-ARG-LEU-NH2 | 171436-38-7 | C29H56N10O7 |
| hydrogen (glycinato-N,O)[sulphato(2-)-O,O']ferrate(1-) | 17169-60-7 | C2H5FeNO6S |
| H-PHE-CYCLOHEXYLAMIDE | 17186-53-7 | C15H22N2O |
| H-DL-Phe-NH2 | 17193-31-6 | |
| H-CHA-OME HCL | 17193-39-4 | C10H20ClNO2 |
| H-ASP-LEU-NH2 | 17193-68-9 | C10H19N3O4 |
| HEPT-6-ENAL | 17206-61-0 | C7H12O |
| H-LYS(BOC)-PNA | 172422-76-3 | C17H26N4O5 |
| HIS-CYS-LYS-PHE-TRP-TRP | 172546-75-7 | C46H55N11O7S |
| H-LYS-LYS-LYS-SER-PRO-GLY-GLU-TYR-VAL-ASN-ILE-GLU-PHE-GLY-OH | 172615-51-9 | C73H114N18O22 |
| HX 600 | 172705-89-4 | |
| H-D-GLU(OTBU)-OTBU HCL | 172793-31-6 | C13H26ClNO4 |